no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
From genetics to prophylaxis
|
Ferrari, Michel |
|
1997 |
17 |
17_suppl |
p. 2-5 |
article |
2 |
How to define the best efficacy parameters for migraine
|
Tfelt-Hansen, Peer |
|
1997 |
17 |
17_suppl |
p. 6-9 |
article |
3 |
Introduction
|
|
|
1997 |
17 |
17_suppl |
p. 1 |
article |
4 |
Is a central action of acute antimigraine drugs essential?
|
Goadsby, Peter J. |
|
1997 |
17 |
17_suppl |
p. 10-11 |
article |
5 |
Measuring central action of acute antimigraine drugs in humans
|
Schoenen, Jean |
|
1997 |
17 |
17_suppl |
p. 12-16 |
article |
6 |
What is lacking in the treatment of paediatric and adolescent migraine?
|
Massiou, Hélène |
|
1997 |
17 |
17_suppl |
p. 21-24 |
article |
7 |
What is the role of international societies and what could they do better?
|
Antonaci, Fabio |
|
1997 |
17 |
17_suppl |
p. 25-28 |
article |
8 |
Would any acute treatment for migraine demonstrate recurrence?
|
Dahlöf, Carl |
|
1997 |
17 |
17_suppl |
p. 17-20 |
article |